Page last updated: 2024-08-20

fluocortolone and Cutaneous T-Cell Lymphoma

fluocortolone has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coors, EA; von den Driesch, P	1

Trials

1 trial(s) available for fluocortolone and Cutaneous T-Cell Lymphoma

Article	Year
Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy. The British journal of dermatology, 2000, Volume: 143, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Disease-Free Survival; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pilot Projects; Pulse Therapy, Drug; Skin Neoplasms	2000

Article

Year

Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy.

The British journal of dermatology, 2000, Volume: 143, Issue:1

Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Disease-Free Survival; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pilot Projects; Pulse Therapy, Drug; Skin Neoplasms

2000